AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Xovoltib 50mg Tablet

Prescription Icon
Prescription Required

Marketer

Boehringer Ingelheim

Salt Composition

Afatinib dimaleate (50mg)

Overview Xovoltib 50mg Tablet

Erlotinib 50mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be evident immediately; continue treatment as directed, even if improvement is slow. Common side effects include nausea, rash, dry skin, and diarrhea (which can be severe; manage it with prescribed medication and adequate hydration). Regular blood tests may be required. Photosensitivity is possible; use sunscreen and protective clothing when exposed to sunlight. Report any eye irritation, dryness, or redness. Prior to commencing treatment, disclose any respiratory issues, liver or kidney impairment, or current use of antimicrobial drugs. Significant drug interactions are possible; inform your healthcare provider of all medications you are taking. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is mandatory for women undergoing treatment.

Primary Ingredients of Xovoltib 50mg Tablet

There is no text provided to rephrase.

Uses of Xovoltib 50mg Tablet

Lung cancer (excluding small cell)

Major Benefits of Xovoltib 50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Xovoltib 50mg Tablet on an empty stomach.

Common Side effects of Xovoltib 50mg Tablet:

  • Diarrhea
  • Rash
  • Dry skin
  • Nausea
  • Vomiting
  • Loss of appetite
  • Itching
  • Stomatitis (Inflammation of the mouth)
  • Nail disorder

How to use Xovoltib 50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 50mg Xovoltib tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Xovoltib 50mg Tablet works:

Xovoltib 50mg tablets are an anti-neoplastic agent. Their mechanism of action involves the targeted inhibition of enzyme receptors (EGFR, HER2, and HER4), crucial for cancer cell proliferation. This blockage disrupts signaling pathways, thus hindering or slowing cancer progression.

SAFETY ADVICE

AlcoholAlcoholSAFE

Xovoltib 50mg Tablet use alongside alcohol consumption presents no known adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Xovoltib 50mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in emergencies where the potential benefits outweigh the clear dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Xovoltib 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Xovoltib 50mg Tablet on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Xovoltib 50mg tablets in individuals with kidney impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.

LiverLiverSAFE IF PRESCRIBED

Xovoltib 50mg tablets appear to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification of Xovoltib 50mg tablets may be unnecessary in such cases. However, physician consultation is recommended.

What if you forget to take Xovoltib 50mg Tablet :

Omit any missed Xovoltib 50mg Tablet dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Xovoltib 50mg Tablet

LabelValue
Type of Compound Quinazoline-based and butenamide-derived compounds
Potential for Dependence None.
Type of Medication Cancer medications
Mechanism of Action Kinase inhibitors targeting tyrosine

FAQs on Xovoltib 50mg Tablet

Xovoltib 50mg tablets are distinct from both immunotherapies and standard chemotherapeutic agents. Classified as a kinase inhibitor, this anti-cancer medication functions by targeting a specific set of proteins crucial to cancer cell proliferation and metastasis. Its mechanism involves inhibiting these proteins, thus preventing cancerous cell growth and replication.
Maximum blood concentrations of Xovoltib 50mg Tablet occur between two and five hours post-administration. Significant improvements in cancer progression, however, might not be apparent for several weeks or even months. While symptom alleviation may be observed, confirmation of Xovoltib 50mg Tablet efficacy requires specific diagnostic measurements.
Administer Xovoltib 50mg tablets orally, on an empty stomach; at least sixty minutes prior to, or one hundred and eighty minutes following, food consumption. Ingest the tablet whole with water; avoid crushing or fracturing. A single daily dose, at approximately the same time each day, aids adherence. For patients experiencing difficulty swallowing, dissolve the uncrushed tablet in a glass of water, stirring gently for up to fifteen minutes until fully dispersed. Consume the solution immediately, followed by a second glass of water to ensure complete ingestion. Water is the sole permissible solvent.
Treatment with Xovoltib 50mg tablets could reduce fertility in males and females. Individuals with fertility concerns should consult their physician to discuss options such as sperm or egg cryopreservation prior to commencing therapy.
Clinical evidence is lacking to support the concomitant use of Xovoltib 50mg Tablet with other chemotherapeutic agents. Xovoltib 50mg Tablet is indicated for a particular form of lung cancer where previous chemotherapy regimens have proved inadequate.
Xovoltib 50mg tablets do not provide a cure for lung cancer; however, they can extend patient lifespan and potentially shrink tumors.
To minimize skin sensitivity, limit sun exposure while taking Xovoltib 50mg Tablets. Increased sun sensitivity can lead to severe sunburn, rashes, acne, or worsening of existing conditions. Protective measures, such as sunscreen, hats, and sun-protective clothing, are recommended when outdoors.
Xovoltib 50mg Tablet frequently causes diarrhea. Severe diarrhea may result in significant fluid loss (dehydration) and kidney complications, potentially fatal. Increased fluid intake should begin immediately upon diarrhea onset, and a physician should be consulted without delay. Prompt initiation of antidiarrheal medication (such as loperamide) will be prescribed. Dosage reduction or treatment cessation may be implemented by your doctor in cases of severe diarrhea.
Xovoltib 50mg Tablet
13,557
MRP 16,517
17% off